| The hemostatic role of factor XI C Puy, RA Rigg, OJT McCarty Thrombosis research 141, S8-S11, 2016 | 90 | 2016 |
| The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear CP Loren, JE Aslan, RA Rigg, MS Nowak, LD Healy, A Gruber, BJ Druker, ... Thrombosis research 135 (1), 155-160, 2015 | 88 | 2015 |
| Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function RA Rigg, JE Aslan, LD Healy, M Wallisch, MLD Thierheimer, CP Loren, ... American Journal of Physiology-Cell Physiology 310 (5), C373-C380, 2016 | 83 | 2016 |
| Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection L Labberton, E Kenne, AT Long, KF Nickel, A Di Gennaro, RA Rigg, ... Nature communications 7 (1), 12616, 2016 | 81 | 2016 |
| A physical sciences network characterization of circulating tumor cell aggregate transport MR King, KG Phillips, A Mitrugno, TR Lee, AME de Guillebon, ... American Journal of Physiology-Cell Physiology 308 (10), C792-C802, 2015 | 75 | 2015 |
| The safety and efficacy of novel agents targeting factors XI and XII in early phase human trials EP DeLoughery, SR Olson, C Puy, OJT McCarty, JJ Shatzel Seminars in thrombosis and hemostasis 45 (05), 502-508, 2019 | 63 | 2019 |
| Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer … KG Phillips, A Kolatkar, KJ Rees, R Rigg, D Marrinucci, M Luttgen, ... Frontiers in oncology 2, 96, 2012 | 51 | 2012 |
| The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation KG Phillips, AM Lee, GW Tormoen, RA Rigg, A Kolatkar, M Luttgen, ... American Journal of Physiology-Cell Physiology 308 (3), C229-C236, 2015 | 42 | 2015 |
| Factor XII activation promotes platelet consumption in the presence of bacterial-type long-chain polyphosphate in vitro and in vivo J Zilberman-Rudenko, SE Reitsma, C Puy, RA Rigg, SA Smith, EI Tucker, ... Arteriosclerosis, thrombosis, and vascular biology 38 (8), 1748-1760, 2018 | 38 | 2018 |
| Heat shock protein 70 regulates platelet integrin activation, granule secretion and aggregation RA Rigg, LD Healy, MS Nowak, J Mallet, MLD Thierheimer, J Pang, ... American Journal of Physiology-Cell Physiology 310 (7), C568-C575, 2016 | 37 | 2016 |
| US social fragmentation at multiple scales L Hedayatifar, RA Rigg, Y Bar-Yam, AJ Morales Journal of the Royal Society Interface 16 (159), 20190509, 2019 | 36 | 2019 |
| Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions RA Rigg, LD Healy, TT Chu, ATP Ngo, A Mitrugno, J Zilberman-Rudenko, ... Platelets 30 (1), 126-135, 2019 | 36 | 2019 |
| Lysine acetyltransfer supports platelet function JE Aslan, RA Rigg, MS Nowak, CP Loren, SM Baker‐Groberg, J Pang, ... Journal of Thrombosis and Haemostasis 13 (10), 1908-1917, 2015 | 33 | 2015 |
| Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y12 signaling with MRS2395 A Mitrugno, RA Rigg, NB Laschober, ATP Ngo, J Pang, CD Williams, ... Platelets 29 (4), 383-394, 2018 | 29 | 2018 |
| Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach ATP Ngo, MLD Thierheimer, Ö Babur, AD Rocheleau, T Huang, J Pang, ... American Journal of Physiology-Cell Physiology 312 (4), C527-C536, 2017 | 29 | 2017 |
| Regulation of immune cell signaling by activated protein C LD Healy, RA Rigg, JH Griffin, OJT McCarty Journal of leukocyte biology 103 (6), 1197-1203, 2018 | 21 | 2018 |
| Platelet procoagulant phenotype is modulated by a p38-MK2 axis that regulates RTN4/Nogo proximal to the endoplasmic reticulum: utility of pathway analysis Ö Babur, ATP Ngo, RA Rigg, J Pang, ZT Rub, AE Buchanan, A Mitrugno, ... American Journal of Physiology-Cell Physiology 314 (5), C603-C615, 2018 | 19 | 2018 |
| Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug A Mitrugno, JL Sylman, RA Rigg, S Tassi Yunga, JJ Shatzel, CD Williams, ... Platelets 29 (8), 773-778, 2018 | 18 | 2018 |
| Freight time and cost optimization in complex logistics networks E Sert, L Hedayatifar, RA Rigg, A Akhavan, O Buchel, DE Saadi, AA Kar, ... Complexity 2020 (1), 2189275, 2020 | 15 | 2020 |
| Design and utility of a point-of-care microfluidic platform to assess hematocrit and blood coagulation J Zilberman-Rudenko, RM White, DA Zilberman, HHS Lakshmanan, ... Cellular and molecular bioengineering 11, 519-529, 2018 | 14 | 2018 |
Owen JT McCartyProfessor of Biomedical Engineering, Oregon Health & Science UniversityVerified email at ohsu.edu